Skip to main content

Table 1 Main characteristics of patients cohort

From: Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments

Gender

Male

46 (66%)

Female

24 (34%)

Age (y)

Median

65

Range

39-89

Primary site

Lung

34(48%)

Colon

10(14%)

Breast

2(3%)

Pancreas

2 (3%)

Uterus

1 (1,5%)

Sarcoma

6 (9%)

Stomach

3 (4, %)

Prostate

1(1,5%)

Liver

4(6%)

Endometrial

1(1,5%)

Melanoma

1(1,5%)

Unknown

5 (7%)